Elanco Animal Health Inc (ELAN) shares plunged 7.56% in the pre-market session on Tuesday, as the company's financial guidance for the first quarter of 2025 and full-year 2025 fell short of Wall Street expectations.
For the first quarter of 2025, Elanco expects revenue in the range of $1.155 billion to $1.18 billion, missing the consensus estimate of $1.211 billion. The company also guided for adjusted earnings per share of $0.29 to $0.34, slightly below the expected $0.30 per share.
For the full year 2025, Elanco forecasts revenue between $4.445 billion and $4.51 billion, lower than the analysts' consensus of $4.533 billion. The company's adjusted earnings per share guidance of $0.80 to $0.86 also missed the expected $0.90.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.